Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Apr 26, 2016 1:06pm
298 Views
Post# 24811067

RE:RE:RE:RE:RE:news won't have any significant impact on sp

RE:RE:RE:RE:RE:news won't have any significant impact on sp
EXACTLY my takeaway from the news today.   Candidly, I think PLI has to make this issue clearer.

The fact that 4050 uses a different mechanism of action, and gets these kinds of meaningful results IN ADDITION to the prevailing therapies....  IS HUGE.

The shorts have drawn a line in the sand at $3.48 -$3.50 with almost 325,000 shares SHOWING on the offer.   As we get institutions nibbling away... could get very interesting 
Bullboard Posts